Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Yvonne Paterson

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Anatomy

Genes & Molecular Sequences

Amino Acid Sequence

Concepts & Ideas

Physiology

Lymphocyte Activation

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
15
Pan, Zhixing
6
Weiss, Susan
6
Cooper, Helen
6
Maciag, Paulo Cesar
5
Lavi, Ehud
5
Wallecha, Anu
5
Sewell, Duane
5
Neeson, Paul
5
Singh, Reshma
4
Matthews, AE
4
Hussain, Farzana
4
Beatty, Gregory
3
Dominiecki, Mary
3
Isaacs, Stuart
3
Mata, M

Sign-in to see all Coauthors

Publications

TOP 3
Kim Sun Hee; Castro Francisco; Paterson Yvonne; Gravekamp Claudia
High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action.
Cooper Helen M; Paterson Yvonne
Production of polyclonal antisera.
Mustafa Waleed; Maciag Paulo Cesar; Pan Zhen-kun; Weaver Jessica R; Xiao Yuhong; Isaacs Stuart N; Paterson Yvonne
Listeria monocytogenes delivery of HPV-16 major capsid protein L1 induces systemic and mucosal cell-mediated CD4+ and CD8+ T-cell responses after oral immunization.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Yvonne Paterson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Kim Sun Hee; Castro Francisco; Paterson Yvonne; Gravekamp Claudia
High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action.
Cancer research 2009;69(14):5860-6.
2009: Cooper Helen M; Paterson Yvonne
Production of polyclonal antisera.
Current protocols in neuroscience / editorial board, Jacqueline N. Crawley ... [et al.] 2009;Chapter 5():Unit 5.5.
2009: Mustafa Waleed; Maciag Paulo Cesar; Pan Zhen-kun; Weaver Jessica R; Xiao Yuhong; Isaacs Stuart N; Paterson Yvonne
Listeria monocytogenes delivery of HPV-16 major capsid protein L1 induces systemic and mucosal cell-mediated CD4+ and CD8+ T-cell responses after oral immunization.
Viral immunology 2009;22(3):195-204.
2009: Seavey Matthew M; Maciag Paulo C; Al-Rawi Nada; Sewell Duane; Paterson Yvonne
An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(9):5537-46.
2009: Seavey Matthew M; Pan Zhen-Kun; Maciag Paulo C; Wallecha Anu; Rivera Sandra; Paterson Yvonne; Shahabi Vafa
A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(3):924-32.
2009: Wallecha Anu; Maciag Paulo Cesar; Rivera Sandra; Paterson Yvonne; Shahabi Vafa
Construction and characterization of an attenuated Listeria monocytogenes strain for clinical use in cancer immunotherapy.
Clinical and vaccine immunology : CVI 2009;16(1):96-103.
2009: Wallecha Anu; Carroll Kyla Driscoll; Maciag Paulo Cesar; Rivera Sandra; Shahabi Vafa; Paterson Yvonne
Multiple effector mechanisms induced by recombinant Listeria monocytogenes anticancer immunotherapeutics.
Advances in applied microbiology 2009;66():1-27.
2008: Maciag Paulo Cesar; Seavey Matthew M; Pan Zhen-Kun; Ferrone Soldano; Paterson Yvonne
Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature.
Cancer research 2008;68(19):8066-75.
2008: Kim S H; Castro F; Gonzalez D; Maciag P C; Paterson Y; Gravekamp C
Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases.
British journal of cancer 2008;99(5):741-9.
2008: Sewell Duane A; Pan Zhen Kun; Paterson Yvonne
Listeria-based HPV-16 E7 vaccines limit autochthonous tumor growth in a transgenic mouse model for HPV-16 transformed tumors.
Vaccine 2008;26(41):5315-20.
2008: Shahabi Vafa; Reyes-Reyes Mariela; Wallecha Anu; Rivera Sandra; Paterson Yvonne; Maciag Paulo
Development of a Listeria monocytogenes based vaccine against prostate cancer.
Cancer immunology, immunotherapy : CII 2008;57(9):1301-13.
2008: Neeson Paul; Pan Zhen Kun; Paterson Yvonne
Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma.
Cancer immunology, immunotherapy : CII 2008;57(4):493-505.
2008: Cooper Helen M; Paterson Yvonne
Production of polyclonal antisera.
Current protocols in cytometry / editorial board, J. Paul Robinson, managing editor ... [et al.] 2008;Appendix 3():Appendix 3I.
2008: Cooper Helen M; Paterson Yvonne
Production of polyclonal antisera.
Current protocols in molecular biology / edited by Frederick M. Ausubel ... [et al.] 2008;Chapter 11():Unit 11.12.
2008: Wood Laurence M; Guirnalda Patrick D; Seavey Matthew M; Paterson Yvonne
Cancer immunotherapy using Listeria monocytogenes and listerial virulence factors.
Immunologic research 2008;42(1-3):233-45.
2007: Singh Reshma; Paterson Yvonne
In the FVB/N HER-2/neu transgenic mouse both peripheral and central tolerance limit the immune response targeting HER-2/neu induced by Listeria monocytogenes-based vaccines.
Cancer immunology, immunotherapy : CII 2007;56(6):927-38.
2007: Peng Xiaohui; Treml John; Paterson Yvonne
Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy.
Cancer immunology, immunotherapy : CII 2007;56(6):797-806.
2007: Singh Reshma; Paterson Yvonne
Immunoediting sculpts tumor epitopes during immunotherapy.
Cancer research 2007;67(5):1887-92.
2007: Souders Nicholas C; Sewell Duane A; Pan Zhen-Kun; Hussain S Farzana; Rodriguez Alexander; Wallecha Anu; Paterson Yvonne
Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer.
Cancer immunity : a journal of the Academy of Cancer Immunology 2007;7():2.
2006: Neeson Paul; Boyer Jean; Kumar Sanjeev; Lewis Mark G; Mattias Lennox; Veazey Ron; Weiner David; Paterson Yvonne
A DNA prime-oral Listeria boost vaccine in rhesus macaques induces a SIV-specific CD8 T cell mucosal response characterized by high levels of alpha4beta7 integrin and an effector memory phenotype.
Virology 2006;354(2):299-315.
2006: Singh Reshma; Paterson Yvonne
Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy.
Expert review of vaccines 2006;5(4):541-52.
2006: Singh Reshma; Paterson Yvonne
Vaccination strategy determines the emergence and dominance of CD8+ T-cell epitopes in a FVB/N rat HER-2/neu mouse model of breast cancer.
Cancer research 2006;66(15):7748-57.
2006: Paterson Yvonne
When it comes to CTL recognition, size does matter.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(9):5139-40.
2006: Boyer Jean D; Maciag Paulo C; Parkinson Rose; Wu Ling; Lewis Mark G; Weiner David B; Paterson Yvonne
Rhesus macaques with high levels of vaccine induced IFN-gamma producing cells better control viral set-point following challenge with SIV239.
Vaccine 2006;24(21):4498-502.
2006: Souders N C; Verch T; Paterson Y
In vivo bactofection: listeria can function as a DNA-cancer vaccine.
DNA and cell biology 2006;25(3):142-51.
2006: Neeson Paul; Paterson Yvonne
Effects of the tumor microenvironment on the efficacy of tumor immunotherapy.
Immunological investigations 2006;35(3-4):359-94.
2005: Paterson Yvonne; Maciag Paulo Cesar
Listeria-based vaccines for cancer treatment.
Current opinion in molecular therapeutics 2005;7(5):454-60.
2005: Singh Reshma; Dominiecki Mary E; Jaffee Elizabeth M; Paterson Yvonne
Fusion to Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(6):3663-73.
2005: Maciag Paulo Cesar; Paterson Yvonne
Technology evaluation: HspE7 (Stressgen).
Current opinion in molecular therapeutics 2005;7(3):256-63.
2005: Hussain S Farzana; Paterson Yvonne
What is needed for effective antitumor immunotherapy? Lessons learned using Listeria monocytogenes as a live vector for HPV-associated tumors.
Cancer immunology, immunotherapy : CII 2005;54(6):577-86.
2005: Dominiecki Mary E; Beatty Gregory L; Pan Zhen-Kun; Neeson Paul; Paterson Yvonne
Tumor sensitivity to IFN-gamma is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors.
Cancer immunology, immunotherapy : CII 2005;54(5):477-88.
2005: Boyer Jean D; Robinson Tara M; Maciag Paulo C; Peng Xiaohui; Johnson Ross S; Pavlakis George; Lewis Mark G; Shen Anding; Siliciano Robert; Brown Charles R; Weiner David B; Paterson Yvonne
DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication.
Virology 2005;333(1):88-101.
2004: Sewell Duane A; Shahabi Vafa; Gunn George R; Pan Zhen-Kun; Dominiecki Mary E; Paterson Yvonne
Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7.
Cancer research 2004;64(24):8821-5.
2004: Verch Thorsten; Pan Zhen-Kun; Paterson Yvonne
Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccines.
Infection and immunity 2004;72(11):6418-25.
2004: Hussain S Farzana; Paterson Yvonne
CD4+CD25+ regulatory T cells that secrete TGFbeta and IL-10 are preferentially induced by a vaccine vector.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(5):339-46.
2004: Paterson Yvonne; Johnson Ross S
Progress towards the use of Listeria monocytogenes as a live bacterial vaccine vector for the delivery of HIV antigens.
Expert review of vaccines 2004;3(4 Suppl):S119-34.
2004: Neeson P; Paterson Y
A new multi-parameter flow cytometric assay for monitoring lymphoma growth and spread in a pre-clinical murine model for human lymphoma.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2004;60(1):8-20.
2004: Peng Xiaohui; Hussain S Farzana; Paterson Yvonne
The ability of two Listeria monocytogenes vaccines targeting human papillomavirus-16 E7 to induce an antitumor response correlates with myeloid dendritic cell function.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(10):6030-8.
2004: Kwak Heesun; Mustafa Waleed; Speirs Kendra; Abdool Asha J; Paterson Yvonne; Isaacs Stuart N
Improved protection conferred by vaccination with a recombinant vaccinia virus that incorporates a foreign antigen into the extracellular enveloped virion.
Virology 2004;322(2):337-48.
2004: Sewell Duane A; Douven Dennis; Pan Zhen-Kun; Rodriguez Alex; Paterson Yvonne
Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine.
Archives of otolaryngology--head & neck surgery 2004;130(1):92-7.
2003: Peters Christian; Peng Xiaohui; Douven Dennis; Pan Zhen-Kun; Paterson Yvonne
The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(10):5176-87.
2003: Salzman Nita H; Ghosh Dipankar; Huttner Kenneth M; Paterson Yvonne; Bevins Charles L
Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin.
Nature 2003;422(6931):522-6.
2003: Salzman Nita H; Chou Margaret M; de Jong Hendrik; Liu Lide; Porter Edith M; Paterson Yvonne
Enteric salmonella infection inhibits Paneth cell antimicrobial peptide expression.
Infection and immunity 2003;71(3):1109-15.
2003: Peters Christian; Paterson Yvonne
Enhancing the immunogenicity of bioengineered Listeria monocytogenes by passaging through live animal hosts.
Vaccine 2003;21(11-12):1187-94.
2003: Paterson Yvonne
Rational approaches to immune regulation.
Immunologic research 2003;27(2-3):451-62.
2002: Salzman Nita H; de Jong Hendrik; Paterson Yvonne; Harmsen Hermie J M; Welling Gjalt W; Bos Nicolaas A
Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria.
Microbiology (Reading, England) 2002;148(Pt 11):3651-60.
2002: Matthews A E; Lavi E; Weiss S R; Paterson Y
Neither B cells nor T cells are required for CNS demyelination in mice persistently infected with MHV-A59.
Journal of neurovirology 2002;8(3):257-64.
2002: Matthews A E; Weiss S R; Paterson Y
Murine hepatitis virus--a model for virus-induced CNS demyelination.
Journal of neurovirology 2002;8(2):76-85.
2001: Gunn G R; Zubair A; Peters C; Pan Z K; Wu T C; Paterson Y
Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(11):6471-9.
2001: Matthews A E; Weiss S R; Shlomchik M J; Hannum L G; Gombold J L; Paterson Y
Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(9):5254-63.
2001: Lamikanra A; Pan Z K; Isaacs S N; Wu T C; Paterson Y
Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site.
Journal of virology 2001;75(20):9654-64.
2001: Cooper H M; Paterson Y
Production of polyclonal antisera.
Current protocols in immunology / edited by John E. Coligan ... [et al.] 2001;Chapter 2():Unit 2.4.
2001: Cooper H M; Paterson Y
Production of polyclonal antisera.
Current protocols in neuroscience / editorial board, Jacqueline N. Crawley ... [et al.] 2001;Chapter 5():Unit 5.5.
2001: Cooper H M; Paterson Y
Determination of the specific antibody titer.
Current protocols in molecular biology / edited by Frederick M. Ausubel ... [et al.] 2001;Chapter 11():Unit11.17.
2001: Cooper H M; Paterson Y
Purification of immunoglobulin G fraction from antiserum, ascites fluid, or hybridoma supernatant.
Current protocols in molecular biology / edited by Frederick M. Ausubel ... [et al.] 2001;Chapter 11():Unit11.14.
2001: Cooper H M; Paterson Y
Production of polyclonal antisera.
Current protocols in cell biology / editorial board, Juan S. Bonifacino ... [et al.] 2001;Chapter 16():Unit 16.2.
2001: Gunn G R; Peters C; Paterson Y
Listeriolysin--a useful cytolysin.
Trends in microbiology 2001;9(4):161-2.
2001: Gérard C M; Baudson N; Kraemer K; Bruck C; Garçon N; Paterson Y; Pan Z K; Pardoll D
Therapeutic potential of protein and adjuvant vaccinations on tumour growth.
Vaccine 2001;19(17-19):2583-9.
2001: Weiskirch L M; Pan Z K; Paterson Y
The tumor recall response of antitumor immunity primed by a live, recombinant Listeria monocytogenes vaccine comprises multiple effector mechanisms.
Clinical immunology (Orlando, Fla.) 2001;98(3):346-57.
2001: Argyris E G; Vanderkooi J M; Paterson Y
Mutagenesis of key residues identifies the connection subdomain of HIV-1 reverse transcriptase as the site of inhibition by heme.
European journal of biochemistry / FEBS 2001;268(4):925-31.
2001: Beatty G; Paterson Y
IFN-gamma-dependent inhibition of tumor angiogenesis by tumor-infiltrating CD4+ T cells requires tumor responsiveness to IFN-gamma.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(4):2276-82.
2001: Mata M; Yao Z J; Zubair A; Syres K; Paterson Y
Evaluation of a recombinant Listeria monocytogenes expressing an HIV protein that protects mice against viral challenge.
Vaccine 2001;19(11-12):1435-45.
2001: Matthews A E; Weiss S R; Lavi E; Shlomchik M; Paterson Y
The role of B cells in mouse hepatitis virus infection and pathology.
Advances in experimental medicine and biology 2001;494():363-8.
2001: Beatty G L; Paterson Y
Regulation of tumor growth by IFN-gamma in cancer immunotherapy.
Immunologic research 2001;24(2):201-10.
2000: Beatty G L; Paterson Y
IFN-gamma can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigen.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(10):5502-8.
2000: Mata M; Paterson Y
Listeria monocytogenes as an alternative vaccine vector for HIV.
Archivum immunologiae et therapiae experimentalis 2000;48(3):151-62.
1999: Pan Z K; Weiskirch L M; Paterson Y
Regression of established B16F10 melanoma with a recombinant Listeria monocytogenes vaccine.
Cancer research 1999;59(20):5264-9.
1999: Mata M; Paterson Y
Th1 T cell responses to HIV-1 Gag protein delivered by a Listeria monocytogenes vaccine are similar to those induced by endogenous listerial antigens.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(3):1449-56.
1999: Saito N G; Chang H C; Paterson Y
Recognition of an MHC class I-restricted antigenic peptide can be modulated by para-substitution of its buried tyrosine residues in a TCR-specific manner.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(10):5998-6008.
1999: Argyris E G; Vanderkooi J M; Venkateswaran P S; Kay B K; Paterson Y
The connection domain is implicated in metalloporphyrin binding and inhibition of HIV reverse transcriptase.
The Journal of biological chemistry 1999;274(3):1549-56.
1998: Mata M; Travers P J; Liu Q; Frankel F R; Paterson Y
The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(6):2985-93.
1998: Mylvaganam S E; Paterson Y; Getzoff E D
Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution.
Journal of molecular biology 1998;281(2):301-22.
1998: Stang E; Guerra C B; Amaya M; Paterson Y; Bakke O; Mellins E D
DR/CLIP (class II-associated invariant chain peptides) and DR/peptide complexes colocalize in prelysosomes in human B lymphoblastoid cells.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(10):4696-707.
1998: Paterson Y
Rational approaches to immune regulation.
Immunologic research 1998;17(1-2):191-207.
1997: Saito N G; Paterson Y
Contribution of peptide backbone atoms to binding of an antigenic peptide to class I major histocompatibility complex molecule.
Molecular immunology 1997;34(16-17):1133-45.
1997: Weiskirch L M; Paterson Y
Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease.
Immunological reviews 1997;158():159-69.
1997: Sutherland R M; Chua M M; Lavi E; Weiss S R; Paterson Y
CD4+ and CD8+ T cells are not major effectors of mouse hepatitis virus A59-induced demyelinating disease.
Journal of neurovirology 1997;3(3):225-8.
1997: Ikonomidis G; Portnoy D A; Gerhard W; Paterson Y
Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines.
Vaccine 1997;15(4):433-40.
1996: Paterson Y; Ikonomidis G
Recombinant Listeria monocytogenes cancer vaccines.
Current opinion in immunology 1996;8(5):664-9.
1996: Chunduru S K; Sutherland R M; Stewart G A; Doms R W; Paterson Y
Exploitation of the Vbeta8.2 T cell receptor in protection against experimental autoimmune encephalomyelitis using a live vaccinia virus vector.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(12):4940-5.
1995: Frankel F R; Hegde S; Lieberman J; Paterson Y
Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(10):4775-82.
1995: Pan Z K; Ikonomidis G; Pardoll D; Paterson Y
Regression of established tumors in mice mediated by the oral administration of a recombinant Listeria monocytogenes vaccine.
Cancer research 1995;55(21):4776-9.
1995: Sutherland R M; Brassell S; Liu Q; Paterson Y
The self antigen heme evades immune recognition by sequestration in some hemoproteins.
European journal of immunology 1995;25(7):1810-4.
1995: Pan Z K; Ikonomidis G; Lazenby A; Pardoll D; Paterson Y
A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours.
Nature medicine 1995;1(5):471-7.
1995: Sutherland R M; Pan Z K; Caton A J; Tang X X; Cerasoli D M; Paterson Y
T cells from unprimed mice respond to the self antigen heme, in a class II restricted manner, at a frequency similar to alloresponses.
International immunology 1995;7(5):771-83.
1995: Zhang Y Z; Paterson Y; Roder H
Rapid amide proton exchange rates in peptides and proteins measured by solvent quenching and two-dimensional NMR.
Protein science : a publication of the Protein Society 1995;4(4):804-14.
1995: Gombold J L; Sutherland R M; Lavi E; Paterson Y; Weiss S R
Mouse hepatitis virus A59-induced demyelination can occur in the absence of CD8+ T cells.
Microbial pathogenesis 1995;18(3):211-21.
1995: Murphy K P; Freire E; Paterson Y
Configurational effects in antibody-antigen interactions studied by microcalorimetry.
Proteins 1995;21(2):83-90.
1995: Lavi E; Wang Q; Gombold J; Sutherland R; Paterson Y; Weiss S
Pathology of MHV-A59 infection in beta 2 microglobulin negative mice.
Advances in experimental medicine and biology 1995;380():179-81.
1994: Ikonomidis G; Paterson Y; Kos F J; Portnoy D A
Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes.
The Journal of experimental medicine 1994;180(6):2209-18.
1994: Sheil J M; Schell T D; Shepherd S E; Klimo G F; Kioschos J M; Paterson Y
Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
European journal of immunology 1994;24(9):2141-9.
1994: Maki P A; Paterson Y; Kennedy A R
Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeans.
Nutrition and cancer 1994;22(2):185-93.
1993: Tsiagbe V K; Asakawa J; Miranda A; Sutherland R M; Paterson Y; Thorbecke G J
Syngeneic response to SJL follicular center B cell lymphoma (reticular cell sarcoma) cells is primarily in V beta 16+ CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(12):5519-28.
1992: Mayne L; Paterson Y; Cerasoli D; Englander S W
Effect of antibody binding on protein motions studied by hydrogen-exchange labeling and two-dimensional NMR.
Biochemistry 1992;31(44):10678-85.
1992: Schafer R; Portnoy D A; Brassell S A; Paterson Y
Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(1):53-9.
1992: Paterson Y
Mapping antibody binding sites on protein antigens.
Nature 1992;356(6368):456-7.
1992: Sheil J M; Shepherd S E; Klimo G F; Paterson Y
Identification of an autologous insulin B chain peptide as a target antigen for H-2Kb-restricted cytotoxic T lymphocytes.
The Journal of experimental medicine 1992;175(2):545-52.
1991: Mylvaganam S E; Paterson Y; Kaiser K; Bowdish K; Getzoff E D
Biochemical implications from the variable gene sequences of an anti-cytochrome c antibody and crystallographic characterization of its antigen-binding fragment in free and antigen-complexed forms.
Journal of molecular biology 1991;221(2):455-62.
1991: Paterson Y
The structural basis of protein antigenicity.
International reviews of immunology 1991;7(2):121-8.
1991: Sutherland R M; Paterson Y; Scherle P A; Gerhard W; Caton A J
A new mouse T-cell receptor alpha chain variable region family.
Immunogenetics 1991;34(6):372-5.
1990: Paterson Y; Englander S W; Roder H
An antibody binding site on cytochrome c defined by hydrogen exchange and two-dimensional NMR.
Science (New York, N.Y.) 1990;249(4970):755-9.
1990: Collawn J F; Paterson Y
Stabilization of helical structure in two 17-residue amphipathic analogues of the C-terminal peptide of cytochrome C.
Biopolymers 1990;29(8-9):1289-96.
1990: Sorger S B; Paterson Y; Fink P J; Hedrick S M
T cell receptor junctional regions and the MHC molecule affect the recognition of antigenic peptides by T cell clones.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(3):1127-35.
1989: Bhayani H; Paterson Y
Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.
The Journal of experimental medicine 1989;170(5):1609-25.
1989: Collawn J F; Bhayani H; Paterson Y
An analysis of the physical properties of peptides that influence the pigeon cytochrome c specific T lymphocyte response.
Molecular immunology 1989;26(11):1069-79.
1989: Wallace C J; Mascagni P; Chait B T; Collawn J F; Paterson Y; Proudfoot A E; Kent S B
Substitutions engineered by chemical synthesis at three conserved sites in mitochondrial cytochrome c. Thermodynamic and functional consequences.
The Journal of biological chemistry 1989;264(26):15199-209.
1989: Oertle M; Immergluck K; Paterson Y; Bosshard H R
Mapping of four discontiguous antigenic determinants on horse cytochrome c.
European journal of biochemistry / FEBS 1989;182(3):699-704.
1989: Cooper H M; Klinman N R; Paterson Y
The autoantigenic response to rabbit cytochrome c.
European journal of immunology 1989;19(2):315-22.
1988: Cooper H M; Corradin G; Paterson Y
The heme moiety of cytochrome c is an autoreactive Ir gene-restricted T cell epitope.
The Journal of experimental medicine 1988;168(3):1127-43.
1988: Bhayani H; Carbone F R; Paterson Y
The activation of pigeon cytochrome c-specific T cell hybridomas by antigenic peptides is influenced by non-native sequences at the amino terminus of the determinant.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(2):377-82.
1988: Collawn J F; Wallace C J; Proudfoot A E; Paterson Y
Monoclonal antibodies as probes of conformational changes in protein-engineered cytochrome c.
The Journal of biological chemistry 1988;263(18):8625-34.
1988: Fox B S; Carbone F R; Germain R N; Paterson Y; Schwartz R H
Processing of a minimal antigenic peptide alters its interaction with MHC molecules.
Nature 1988;331(6156):538-40.
1987: Cooper H M; Jemmerson R; Hunt D F; Griffin P R; Yates J R; Shabanowitz J; Zhu N Z; Paterson Y
Site-directed chemical modification of horse cytochrome c results in changes in antigenicity due to local and long-range conformational perturbations.
The Journal of biological chemistry 1987;262(24):11591-7.
1987: Carbone F R; Staerz U D; Paterson Y
A new T helper cell specificity within the pigeon cytochrome c determinant 95-104.
European journal of immunology 1987;17(6):897-9.
1987: Carbone F R; Fox B S; Schwartz R H; Paterson Y
The use of hydrophobic, alpha-helix-defined peptides in delineating the T cell determinant for pigeon cytochrome c.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(6):1838-44.
1986: Jemmerson R; Paterson Y
Mapping epitopes on a protein antigen by the proteolysis of antigen-antibody complexes.
Science (New York, N.Y.) 1986;232(4753):1001-4.
1985: Carbone F R; Paterson Y
Monoclonal antibodies to horse cytochrome c expressing four distinct idiotypes distribute among two sites on the native protein.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(4):2609-16.
1985: Jemmerson R; Paterson Y
Mobility and evolutionary variability factors in protein antigenicity.
Nature 1985;317(6032):89-90.
1985: Jemmerson R; Morrow P R; Klinman N R; Paterson Y
Analysis of an evolutionarily conserved antigenic site on mammalian cytochrome c using synthetic peptides.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(5):1508-12.
1985: Paterson Y
Delineation and conformational analysis of two synthetic peptide models of antigenic sites on rodent cytochrome c.
Biochemistry 1985;24(4):1048-55.
1985: Tainer J A; Getzoff E D; Paterson Y; Olson A J; Lerner R A
The atomic mobility component of protein antigenicity.
Annual review of immunology 1985;3():501-35.
1982: Paterson Y; Stimson E R; Evans D J; Leach S J; Scheraga H A
Solution conformations of oligomers of alpha-aminoisobutyric acid.
International journal of peptide and protein research 1982;20(5):468-80.
1980: Paterson Y; Leach S J
Chain fission of poly-L-glutamic acid by a water-soluble carbodiimide.
Biochemical and biophysical research communications 1980;95(4):1722-9.
1972: Paterson Y; Lawrence E F
Factors affecting serum creatine phosphokinase levels in normal adult females.
Clinica chimica acta; international journal of clinical chemistry 1972;42(1):131-9.
1971: Paterson Y
A new screening test for serum creatine phosphokinase.
Clinica chimica acta; international journal of clinical chemistry 1971;34(3):373-6.

Sign-in to see more